about
Α molecular epidemiological analysis of adenoviruses from excess conjunctivitis cases.Evaluation of Two Loop-mediated Isothermal Amplification Methods for the Detection of Salmonella Enteritidis and Listeria Monocytogenes in Artificially Contaminated Ready-to-Eat Fresh Produce.Pre-pregnancy obesity: maternal, neonatal and childhood outcomes.Cotransport of human adenoviruses with clay colloids and TiO2 nanoparticles in saturated porous media: Effect of flow velocity.Molecular Characterization and Phylogenetic Analysis of Pseudomonas aeruginosa Isolates Recovered from Greek Aquatic Habitats Implementing the Double-Locus Sequence Typing Scheme.Pitfalls in the identification of Enterococcus species and the detection of vanA and vanB genes.Performance of three small-scale wastewater treatment plants. A challenge for possible re use.Efficacy of three light technologies for reducing microbial populations in liquid suspensions.Prepregnancy maternal obesity and fetal-perinatal death in a Mediterranean country.Evaluation of Antimicrobial Efficiency of New Polymers Comprised by Covalently Attached and/or Electrostatically Bound Bacteriostatic Species, Based on Quaternary Ammonium Compounds.Polymeric Quaternary Ammonium-Containing Coatings with Potential Dual Contact-Based and Release-Based Antimicrobial Activity.Assessment of the Virological Quality of Marine and Running Surface Waters in NW Greece: A Case Study.National Survey of Morbidity and Risk Factors (EMENO): Protocol for a Health Examination Survey Representative of the Adult Greek PopulationAssessment of the Incidence of Human Adenovirus in Surface Waters of Southwest Greece: Vouraikos River as a Case StudyEfficacy of Topical Ofloxacin 0.3 % Administration on Conjunctival Bacterial Flora in Diabetic Patients Undergoing Intravitreal InjectionsDesign and Development of a Viral Hepatitis and HIV Infection Screening Program (Hprolipsis) for the General, Greek Roma, and Migrant Populations of Greece: Protocol for Three Cross-Sectional Health Examination SurveysCOVID-19 and Environmental factors. A PRISMA-compliant systematic review
P50
Q33602124-4E26C3A0-B94C-45CD-BB99-B8CF86E8C39DQ37361283-19389EB7-5B60-4926-9D5D-454B948ECC05Q38163689-03DEA8DB-5E3E-4C85-9C87-AADCF1B36ED2Q38820637-677891D6-25DA-4D89-926D-B824A0A050EAQ40391969-96F2FEE9-FB71-4AEA-816E-79627F43C0ABQ40628680-94C25145-B16A-45D2-9E8B-894194C9BC73Q40759151-7D816899-DD70-4687-8A07-B5C3D6F06FC0Q42404971-33794B3E-5E72-40B4-B17B-F844FF787154Q44718392-3F097BA1-670F-45C7-B7D5-EC04867DA587Q46628728-BEDE5DB0-3638-462A-B8F3-3BA8FCFB6394Q48152126-051C23FD-CEA5-46B8-B7D3-351B894CDD27Q52562265-E4A9210E-48F9-4286-AF07-384FD487D3EEQ64250055-B1E084D5-E4B2-4BC8-AD25-9608548A0574Q64374745-CAF09ABA-BAB5-41D4-9B1B-FB5F90F2F497Q88052772-C5AF811D-D38B-4DAA-A69C-1A4C35EDA8A2Q89466433-56A4210B-CB7C-4FCE-9955-D3030995D7E5Q95627555-9247AD6D-36BF-4DCB-B620-7D316E41CBB5
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
A Vantarakis
@en
A Vantarakis
@nl
type
label
A Vantarakis
@en
A Vantarakis
@nl
prefLabel
A Vantarakis
@en
A Vantarakis
@nl
P31
P496
0000-0003-4411-3739